Virgin Australia shares take off on ASX despite Mid-East jitters
After more than four years' absence, Virgin shares relisted on the ASX on Tuesday, rising to $3.23 by market close as investors bet that new management and more streamlined operations would bolster the company's profitability even amid volatile oil prices.
Virgin sold $685 million worth of stock to fund managers and retail investors in an initial public offering this month, floating about 30.2 per cent of the company. Investors paid $2.90 for the stock in the IPO. Virgin, which now has a market value of more than $2.5 billion, is trading under the sharemarket ticker VGN.
Demand from investors had outstripped the number of shares on offer in the IPO, according to Virgin CEO Dave Emerson, which explains the rise in the share price after the stock started trading.
'We were very pleased with the demand, and we definitely can say that the offer was oversubscribed,' Emerson said before the trading debut.
An overall positive market also would have boosted the stock, with the S&P/ASX 200 gaining 1 per cent in its Tuesday session after US President Donald Trump announced a ceasefire between Israel and Iran. The specific timing of the pause remains unclear, with Israel accusing Iran of violating the ceasefire on Tuesday evening AEST, which Iran has denied.
Shares of Virgin's bigger rival Qantas Airways were also up strongly on Tuesday, closing with a gain of 2.4 per cent.
Virgin was delisted from the ASX in 2020 amid mounting debts and losses. Having entered administration, it was bought by US-based Bain Capital, the private equity firm Emerson worked for before joining Virgin's management in 2021.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
9 News
26 minutes ago
- 9 News
Revealed: Millions of Aussies unable to afford retirement
Your web browser is no longer supported. To improve your experience update it here More than 4 million Australians worry they won't be able to afford retirement, new research shows. Up to 20 per cent of Australians fear they will not gain enough from their super or other investments to ever stop working, while one in five said they will have to cut back on their spending, a study from Finder revealed. The Association of Superannuation Funds of Australia recommends singles have $595,000 tucked away and couples have $690,000 to live comfortably in retirement. Millions of Australians now fear they won't be able to afford retirement. (Getty Images/iStockphoto) According to data from the ATO, the average Australian has about $172,000 in super, but the median sits at $66,000 for men and $52,000 for women. As a result, the retirement dream could be out of reach for many Aussies. "Insufficient super or savings could see millions of Aussies facing financial strain in their later years," Pascale Heylar-Moray from Finder said. "More and more people are worried that retirement will arrive before the money does, leaving them underprepared." This means more will have to fall back on measures such as the Age Pension, but Heylar-Morey warns this may not be an option for some: "The Age Pension isn't guaranteed, your assets could disqualify you from receiving it". A further 27 per cent of Aussies are still unsure if they will have enough super to get by in retirement, and 10 per cent believe they will need to utilise other investments to meet the shortfall. Australians are trying to find new measures to be able to retire comfortably (Getty Images/iStockphoto) Aussies are now looking to find new measures to avoid financial pain. Salary sacrificing, where people can send a percentage of their wage directly into their super, can also help build a larger safety net. "Super earnings below $30K are taxed at a maximum of just 15%, which means salary sacrificing into super could help grow your wealth while also lowering your tax," Heylar-Morey said. She also suggested Aussies consistently monitor the performance of their fund. "Make sure that you aren't stuck in a poorly performing fund," she said. "And check regularly that your employer is paying your 12% superannuation Guarantee contributions on time." The information provided on this website is general in nature only and does not constitute personal financial advice. The information has been prepared without taking into account your personal objectives, financial situation or needs. Before acting on any information on this website you should consider the appropriateness of the information having regard to your objectives, financial situation and needs. national money finance Cost of Living Australia CONTACT US
Sky News AU
an hour ago
- Sky News AU
'Not up for negotiation': Aussies expected to save $200m a year from major cap on PBS-listed scripts despite tariff threats to industry
Millions of Australians are expected to save $200m in vital medication fees as a landmark bill caps the price of Pharmaceutical Benefits Scheme (PBS) prescriptions at just $25, down from $31.60. The bill is set to take effect from January 1, as the Labor government takes the first steps to legislate the bill and Prime Minister Anthony Albanese vows to keep his election pledge on cost of living relief. The changes mean the cost of medicines on the PBS could be significantly reduced by over 20 per cent. Minister for Health, Mark Butler said five million Australians will feel the relief in their pockets. The cost of medicine for pension and concession card holders will remain frozen at $7.70 until the end of 2029. The bill which was announced by Labor during the May election campaign is expected to cost the budget $690m over four years. Mr Albanese said it built on a pledge for cost of living relief. 'This is another example of cost of living relief that helps every Australian,' he said. 'The size of your bank balance shouldn't determine the quality of your healthcare. My government will continue to deliver cost of living relief for all Australians.' Mr Butler added general patients' medicines haven't been this cheap since 2004. 'The Albanese Government has been focused on delivering cheaper medicines for Australians," he said. 'Cheaper medicines are good for the hip pocket and good for your health." The Assistant Health Minister, Emma McBride said the bill was set to pass despite US President Donald Trump's 200 per cent tariff threat on pharmaceutical imports. The US is Australia's biggest pharmaceutical export market and if the tariff is implemented it could cost the Australian economy up to $2.8 billion and force pharmas' to hike up their prices. However, Ms McBride said the PBS is not up for negotiation and "it is not a bargaining chip". "Labor introduced the Pharmaceutical Benefits Scheme to make sure that essential medicines were available to all Australians, and with this introduction of legislation to enact our election commitment, it will mean a cap on $25, which will save Australians about $200 million a year, 5.1 million Australians estimated to benefit," she said.
News.com.au
3 hours ago
- News.com.au
Criterion: Don't horse around with the Magnificent Seven dividend stocks this reporting season
• Dwindling yields from the dividend favourites mean investors should saddle up elsewhere • Led by the CBA, the 'Magnificent Seven' account for half of all dividends paid • Investors should avoid swapping growth thoroughbreds for high-yielding donkeys that won't last the distance On the cusp of the August profit reporting season, dividend yield chasers are mulling the top stocks likely to impress with their payouts. This year, they will need to look harder. Combined with elevated share valuations, subdued earnings are likely to diminish the appeal of the dividend faves. Historically, Australian investors have not looked too far in their quest for income. Of the ASX200 stocks, a mere seven account for half of all ASX dividends in 2024. For the record, they are the Big Four banks, BHP (ASX:BHP), Fortescue (ASX:FMG) and Woodside Energy Group (ASX:WDS). (This Magnificent Seven shouldn't be confused with the top US tech stocks which share the same nomenclature). The top dividend payer, the Commonwealth Bank (ASX:CBA) yields a sub-par 2.5% after its monstrous share run. The top 100 stocks account for 97% of the ASX200 index dividends. The average pre-tax yield has fallen to 3.2%. This compares to the historic run rate of 4.5% over the last ten years and 4-6% over the last five decades. "Airbag" protection The manager of Ausbil's active dividend income fund, Michael Price cautions that chasing dividends should not come at the cost of losing capital. With that in mind, the fund positions itself to capture the best dividends from events such as the upcoming reporting season, 'rather than passively buying and holding for a long time'. Atlas Funds Management's Hugh Dive counsels investors to pay close attention to capex requirements: companies needing to replace or upgrade assets won't be going on a dividend spree. Companies exposed to the US are likely to be preserving funds, given the 'what will Donald do next?' uncertainties. But Dive says dividend-paying stocks provide 'airbag' protection in a downturn: when yields become high enough, investors will jump back in. Don't bank on the banks Price says of the banks: 'I don't see much dividend growth coming over the next two or three years.' That said, the CBA remains the fund's biggest holding, as it's the next Big Four bank to pay a dividend (the others have a September 30 balance date). Ausbil's preferred Big Four bank is the runt of the litter, the Australia and New Zealand Banking Group (ASX:ANZ). But Price believes there's better value in Macquarie Group (ASX:MQG), which pays a lower div than the Big Four but makes up for this with its superior growth potential. 'It's always hard to know exactly where Macquarie will make its money, but it is a well-run business that benefits from volatility," he says. Insurers offer premium yields Price says domestic insurers such as Suncorp Group (ASX:SUN) and Insurance Australia (ASX:IAG) continue to post strong premium growth whilst managing claims pressure. The same applies to the listed health insurer Medibank Private (ASX:MPL) and NIB Holdings (ASX:NHF). Ausbil has also got back on the old dividend warhorse Telstra (ASX:TLS), given more rational competition in the mobile sector. Price cites the 'quality end' of discretionary retailing: stocks such as JB HiFi (ASX:JBH), or the nation's biggest car yard, AP Eagers. But for the first time in years, Ausbil won't be riding into the reporting season with dividend faithfuls Woolworths (ASX:WOW) and Coles Group (ASX:COL). These grocers have been stabled because of competitive pressure (read Aldi), regulatory scrutiny over profit gouging claims, management upheaval and elevated capital spending. Sonic booms on pathology demand Atlas's Dive nominates Sonic Healthcare (ASX:SHL), the world's biggest pathology provider trading on an approximate 4.5% yield. Sonic benefits from an older population and one of the few companies genuinely likely to benefit from AI. Unlike other health companies, pathology providers don't have to spend a poultice on R&D. At the smaller end, Plato Investment Management's Peter Gardner likes Ventia Services (ASX:VNT), which manages infrastructure and public assets. In December the competition regulator took the company to task over defence contracts, but the company seems to have weathered the storm. Ventia yields round 5%. Digging up dividend delights Despite their earnings being subject to volatile commodity prices, the miners are cementing a new reputation for reliable dividends. Given the resilient iron price, the payouts from BHP, Rio Tinto (ASX:RIO) and Fortescue could pleasantly surprise. Fortescue's dividend capacity is bolstered by the $1 billion-plus it won't spend on two ditched hydrogen projects. Price notes BHP paid an interim div one-third of that of two years ago. But the miner's final payout should equate to an attractive yield (of around 3.5%, before franking). So not all of the Magnificent Seven posse should be run out of town. For the gold miners, cash is flowing in like rivers of – er -gold. These days, they're more inclined to share the spoils with investors rather than chase the next El Dorado deposit.
